• June 24, 2024

BAT: Modern Oral Comparable to NRT

 BAT: Modern Oral Comparable to NRT

New research published today indicates that BAT’s modern oral products in the form of tobacco-free nicotine pouches have a toxicant profile that is comparable to nicotine-replacement therapies (NRTs) and much lower than traditional oral snus, a category of products that when used as the sole nicotine product is already established as a reduced-risk product compared with cigarettes.

The study, published in Drug and Chemical Toxicology, analyzed four variants of one of BAT’s modern oral nicotine pouch products Lyft+, three snus products, and two different NRT products in a lozenge and a gum format. Each of these products was tested for a range of known harmful and potentially harmful constituents.

The results showed that the modern oral products had a comparable toxicant profile to NRTs, which are currently considered to be the least risky of all nicotine products. The study also estimated that users of the studied modern oral products are likely to be exposed to far fewer and significantly lower levels of toxicants than those who use snus.

According to BAT, the findings suggest that modern oral products, such as Lyft and Velo, should be placed close to NRTs at the lowest exposure end of the nicotine product toxicant delivery continuum.

“These results add to the growing body of evidence to support the reduced-risk potential of modern oral products compared to continuing to smoke,” said Aaron Williams, head of science and R&D, in a statement.

These results add to the growing body of evidence to support the reduced-risk potential of modern oral products compared to continuing to smoke.

Aaron Williams, head of science and R&D, BAT

“They provide important new evidence to support the role of modern oral products in tobacco harm reduction by demonstrating that they have far fewer and much lower levels of toxicants compared with cigarette smoke and even compared with Swedish-style snus, which is already well established as a reduced-risk product when used as the sole nicotine product.

“This means smokers looking for an alternative nicotine product have another alternative offering greatly reduced exposure to toxicants that comes in an oral format that some may find convenient and easy to use.”